Radiodermatitis Market Size Was Valued at USD 1.5 Billion in 2023, and is Projected to Reach USD 2.5 Billion by 2032, Growing at a CAGR of 5.81% From 2024-2032.
Radiodermatitis is the skin reactions that are induced by ionising radiation during cancer treatment. This condition takes the form of erythema right up to ulceration, which causes substantial distress to patients who are receiving radiation treatment.